Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02349412 · ClinicalTrials.gov registry record · Phase 3
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
A Phase 3 study of Depression and Non-Small Cell Lung Cancer, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- Phase 3
- Development phase
- 405
- Enrollment target
- 20
- Study locations
NCT02349412 is a Phase 3 study of Depression and Non-Small Cell Lung Cancer that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 405 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (48% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT02349412, a Phase 3 study of Depression and Non-Small Cell Lung Cancer, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 405 participants
- Enrollment target
- 20
- Study locations
Study Summary
The study intervention consists of the early integration of palliative care services into standard oncology care in an outpatient setting for patients with advanced lung and non-colorectal gastrointestinal malignancies who are not being treated with curative intent. The palliative care services provided to patients randomized to the intervention will be provided by board-certified physicians and/or advanced practice nurses and will focus on the following areas: (1) developing and maintaining the therapeutic relationship with the patients and family caregivers; (2) assessing and treating patient symptoms; (3) providing support and reinforcement of coping with advanced cancer in patients and family caregivers; (4) assessing and enhancing prognostic awareness and illness understanding in patients and family caregivers; (5) assisting with treatment decision-making; and (6) end-of-life care planning.
Conditions Studied
Interventions
- OTHER Early palliative care
Study Locations (20)
Illinois
- University of Chicago Comprehensive Cancer Center - Chicago
- NorthShore University HealthSystem-Evanston Hospital - Evanston
- NorthShore University HealthSystem-Glenbrook Hospital - Glenview
- NorthShore University HealthSystem-Highland Park Hospital - Highland Park
Minnesota
- Hennepin County Medical Center - Minneapolis
- Mayo Clinic - Rochester
- Park Nicollet Clinic - Saint Louis Park - Saint Louis Park
- Regions Hospital - Saint Paul
New York
- North Shore-LIJ Health System/Center for Advanced Medicine - New Hyde Park
- Columbia University/Herbert Irving Cancer Center - New York
California
- UC San Diego Moores Cancer Center - La Jolla
Hawaii
- Queen's Medical Center - Honolulu
Iowa
- University of Iowa/Holden Comprehensive Cancer Center - Iowa City
Massachusetts
- Massachusetts General Hospital Cancer Center - Boston
Michigan
- Mercy Health Saint Mary's - Grand Rapids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 405 participants |
| Start Date | 2015-06-25 |
| Est. Completion | 2019-07-15 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02349412
The ClinicalTrials.gov registry entry for NCT02349412 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 405 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (48% lower). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Early palliative care is the first listed.
NCT02349412 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Illinois, Minnesota, New York.
Frequently Asked Questions
What is clinical trial NCT02349412 about?
NCT02349412 is a clinical study titled "Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers". The study intervention consists of the early integration of palliative care services into standard oncology care in an outpatient setting for patients with advanced lung and non-colorectal gastrointestinal malignancies who are not being treated with curative intent. The palliative care services prov...
What is the current status of trial NCT02349412?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 405 participants. The study started on 2015-06-25. Estimated completion is 2019-07-15.
What conditions does trial NCT02349412 study?
This clinical trial studies the following conditions: Depression, Non-Small Cell Lung Cancer, Pancreatic Cancer, Gastric Cancer, Esophageal Cancer.
What interventions are being tested in trial NCT02349412?
The interventions under investigation include: Early palliative care (OTHER).
Who is sponsoring clinical trial NCT02349412?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02349412 being conducted?
This trial has 20 study locations across California, Hawaii, Illinois, Iowa, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care
RECRUITING · Phase 3
-
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RECRUITING · Phase 3
-
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
RECRUITING · Phase 3
-
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
RECRUITING · Phase 3
-
Creatine for Depressed Male and Female Methamphetamine Users
RECRUITING · Phase 3
-
E-Mindfulness Approaches for Living After Breast Cancer
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.